
Cross-modality fusion of hematology-based digital and molecular biomarkers for intelligent epidemiological screening and surveillance of hepatocellular carcinoma.
Innovative biosensor achieves 99% accuracy in early HCC detection, surpassing GALAD's 83%. Promising for liquid biopsy advancements! 🔬📈









